DecisionDatabases.com announces a new report “2018 Top 5 Osteoarthritis Pain Drugs Players in North America, Europe, Asia-Pacific, South America, Middle East and Africa” added to its database. The report provides key statistics on the current state of the industry and other analytical data to understand the market.
Painkillers only: Only a simple analgesic effect, but no anti-inflammatory function, such as acetaminophen, tramadol. Acetaminophen side effects, but the analgesic effect is relatively weak, mainly for mild to moderate pain; tramadol analgesic effect is strong, but also side effects are larger, mainly gastrointestinal side effects such as nausea, vomiting and so on.
NSAIDs: With both anti-inflammatory and analgesic effect, suitable for inflammatory pain, for the acute phase of osteoarthritis, joint swelling of the patients to relieve symptoms better. These drugs may lead to nausea, vomiting and other gastrointestinal discomfort, but also increase the risk of gastrointestinal bleeding, so patients with gastro duodenal ulcer in the application of these drugs should consult a digestive physician, plus gastric mucosal protection Drugs or antacid drugs.
Medicines for Osteoarthritis Pain are available as pills, syrups, creams or lotions, or they are injected into a joint.
Osteoarthritis, the most common type of arthritis, is a leading cause of disability. It is a chronic, progressive degenerative joint disease, which is characterized by gradual destruction of the articular cartilage, hypertrophy of the bone margins, and a series of biochemical and morphological changes in the synovial membrane and joint capsule. This results in pain and loss of movement.
The USA osteoarthritis pain drugs market is very concerted market; the revenue of eleven manufacturers accounts about 88% of the total revenue in 2016. The high-end products mainly come from USA and Europe.
The leading manufactures mainly are Johnson & Johnson, Pfizer and GlaxoSmithKline. Johnson & Johnson is the largest manufacturer; its revenue of USA market exceeds 27% in 2016. The next is Pfizer and GlaxoSmithKline.
Over the next five years, LPI(LP Information) projects that Osteoarthritis Pain Drugs will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.
This report studies the global market, especially in North America, Europe, Asia-Pacific, South America, Middle East and Africa, focuses on the top 5 players in each region, with sales, price, revenue and market share from 2013 to 2018, the top players:
Johnson & Johnson
Pfizer
GlaxoSmithKline
Mylan
Lilly
Sanofi
Abbott Laboratories
Bayer
Almatica Pharma
TEVA
Iroko Pharmaceuticals
Download Free Sample Report of Osteoarthritis Pain Drugs Market @
http://www.decisiondatabases.com/contact/download-sample-26162
Market Segment by Regions, this report splits Global into several key Regions, with sales, revenue, market share of top players in these regions, from 2013 to 2018 (forecast), like
North America (United States, Canada and Mexico)
Asia-Pacific (China, Japan, Southeast Asia, India and Korea)
Europe (Germany, UK, France, Italy and Russia etc.)
South America (Brazil, Chile, Peru and Argentina)
Middle East and Africa (Egypt, South Africa, Saudi Arabia)
Split by Product Types, with sales, revenue, price, market share of each type, can be divided into
Oral
Injection
External
Split by applications, this report focuses on sales, market share and growth rate in each application, can be divided into
Medical Care
Personal Care
Table of Contents – Snapshot
1 Osteoarthritis Pain Drugs Market Overview
2 Global Osteoarthritis Pain Drugs Sales, Revenue (Value) and Market Share by Players
3 Global Osteoarthritis Pain Drugs Sales, Revenue (Value) by Regions, Type and Application (2013-2018)
4 North America Top 5 Players Osteoarthritis Pain Drugs Sales, Revenue and Price
5 Europe Top 5 Players Osteoarthritis Pain Drugs Sales, Revenue and Price
6 Asia-Pacific Top 5 Players Osteoarthritis Pain Drugs Sales, Revenue and Price
7 South America Top 5 Players Osteoarthritis Pain Drugs Sales, Revenue and Price
8 Middle East & Africa Top 5 Players Osteoarthritis Pain Drugs Sales, Revenue and Price
9 Global Osteoarthritis Pain Drugs Players Profiles/Analysis
10 Global Osteoarthritis Pain Drugs Market Forecast (2018-2023)
11 Osteoarthritis Pain Drugs Manufacturing Cost Analysis
12 Industrial Chain, Sourcing Strategy and Downstream Buyers
13 Marketing Strategy Analysis, Distributors/Traders
14 Market Effect Factors Analysis
15 Research Findings and Conclusion
16 Appendix
Purchase the Complete Osteoarthritis Pain Drugs Market Research Report @
http://www.decisiondatabases.com/contact/buy-now-26162
About Us:
DecisionDatabases.com is a global business research reports provider, enriching decision makers and strategists with qualitative statistics. DecisionDatabases.com is proficient in providing syndicated research report, customized research reports, company profiles and industry databases across multiple domains.
Our expert research analysts have been trained to map client’s research requirements to the correct research resource leading to a distinctive edge over its competitors. We provide intellectual, precise and meaningful data at a lightning speed.